The said certificate is valid for a period of 3 years and opens up the European and other markets for the company's products
SMDC is a participating authority under Pharmaceutical Inspection Cooperation Scheme (PIC/S)
The company has received a certificate of Good Manufacturing Practice compliance from the Medicines & Healthcare products Regulatory Agency (MHRA) UK
Inspection outcome reinforces company's compliance track record and strengthens its ability to serve regulated markets including the United States
By prioritising absolute compliance, leveraging the power of digital tools, and aligning with government policies, the sector is locking in its future leadership
The Clear Lake facility marks Clariant’s first U.S. site dedicated to PEG excipient production
If approved, CUTX-101 will be the first and only FDA approved treatment available for Menkes disease
The new site enables end-to-end production of viral vector gene therapies
The Ma’anshan site approval covers pastilles, oral liquids, and powders
Subscribe To Our Newsletter & Stay Updated
